Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine
PHASE1
This phase I trial studies the safety and the ability to expand laboratory-...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium